Home/Filings/4/0001765581-19-000027
4//SEC Filing

WILSON KAREN J 4

Accession 0001765581-19-000027

CIK 0001232524other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 7:43 PM ET

Size

9.6 KB

Accession

0001765581-19-000027

Insider Transaction Report

Form 4
Period: 2019-02-28
WILSON KAREN J
VP of Finance & PAO
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-02-28+8,1748,174 total
    Exercise: $140.03Exp: 2029-02-27Ordinary Shares (8,174 underlying)
  • Award

    Ordinary Shares

    2019-02-28+3,50018,963 total
  • Award

    Incentive Stock Option (right to buy)

    2019-02-28+576576 total
    Exercise: $140.03Exp: 2029-02-27Ordinary Shares (576 underlying)
Footnotes (2)
  • [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
  • [F2]These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

Issuer

Jazz Pharmaceuticals plc

CIK 0001232524

Entity typeother

Related Parties

1
  • filerCIK 0001267490

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:43 PM ET
Size
9.6 KB